Table 3.
Linear regression models for birth weight, head circumference, and birth length outcomes predicted by cannabis exposure during pregnancy
| Curtailed use versus previous use of cannabis, but not used during pregnancya |
Prolonged use versus previous use of cannabis, but not used during pregnancyb |
|||||
|---|---|---|---|---|---|---|
| B | 95% CI | p value | B | 95% CI | p value | |
| Birth weight Cannabis in pregnancy − unadjustedc |
−57 | −166 to 53 | 0.31 | −334 | −507 to −160 | <0.001 |
| Cannabis in pregnancy − adjustedd | 12 | −88 to 112 | 0.82 | −228 | −354 to −102 | <0.001 |
| Birth length | ||||||
| Cannabis in pregnancy − unadjustedc | −0.5 | −0.9 to 0.0 | 0.07 | −1.0 | −1.8 to −0.2 | 0.01 |
| Cannabis in pregnancy − adjustedd | −0.1 | −0.7 to 0.5 | 0.75 | −0.5 | −1.6 to 0.6 | 0.41 |
| Head circumference | ||||||
| Cannabis in pregnancy − unadjustedc | −0.1 | −0.4 to 0.3 | 0.74 | −0.6 | −1.2 to −0.1 | 0.03 |
| Cannabis in pregnancy − adjustedd | 0.2 | −0.2 to 0.5 | 0.30 | −0.4 | −0.8 to 0.1 | 0.07 |
N = 4,981 for birth weight; N = 4,797 for birth length; N = 4,895 for head circumference.
N = 4,922 for birth weight; N = 4,736 for birth length; N = 4,838 for head circumference.
The crude regression analyses were restricted to the same study sample as in the adjusted analysis.
Adjusted for a set of confounders: maternal age, education, parity, alcohol use during pregnancy (never, sometimes, and regular/binge), presence of symptoms of anxiety/depression, tobacco smoking in pregnancy (never, sometimes, and daily), use of illicit drugs, use of prescribed medications during pregnancy (opioids and benzodiazepines), work situation, planned pregnancy, and sex.